William Blair analyst Ryan Daniels downgraded Oak Street Health (OSH) to Market Perform from Outperform after CVS Health (CVS) announced the acquisition of Oak Street for $39 per share in cash or $10.6B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OSH:
- Oak Street Health downgraded to Hold from Buy at Canaccord
- Oak Street Health downgraded to Hold from Buy at Truist
- CVS Health says Oak Street Health deal has long term growth, earnings power
- Oak Street Health downgraded to In Line from Outperform at Evercore ISI
- Oak Street Health downgraded to Neutral from Overweight at Piper Sandler